Wave Life Sciences Ltd. (WVE) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 250 transactions totaling $178.6M, demonstrating a bullish sentiment with $77.2M in net insider flow. The most recent transaction on Feb 9, 2026 involved a sale of 3,228 shares valued at $43.4K.
No significant insider buying has been recorded for WVE in the recent period.
No significant insider selling has been recorded for WVE in the recent period.
Based on recent SEC filings, insider sentiment for WVE is bullish with an Insider Alignment Score of 72/100 and a net flow of $77.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Wave Life Sciences Ltd. (WVE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading WVE stock, having executed 250 transactions in the past 90 days. The most active insider is Plc Gsk (Executive), who has made 2 transactions totaling $44.4M.
Get notified when executives and directors at WVE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Vargeese Chandra | See Remarks | Sale | 3,228 | $13.45 | $43.4K | |
| Feb 9, 2026 | Francis Chris | See Remarks | Sale | 1,883 | $13.45 | $25.3K | |
| Feb 9, 2026 | Bolno Paul | Executive | Sale | 10,480 | $13.45 | $141.0K | |
| Feb 9, 2026 | Moran Kyle | Chief Financial Officer | Sale | 3,588 | $13.45 | $48.3K | C-Suite |
| Feb 5, 2026 | Vargeese Chandra | See Remarks | Award | 273,750 | $N/A | $0 | |
| Feb 5, 2026 | Vargeese Chandra | See Remarks | Award | 45,625 | $N/A | $0 | |
| Feb 5, 2026 | Francis Chris | See Remarks | Award | 232,500 | $N/A | $0 | |
| Feb 5, 2026 | Francis Chris | See Remarks | Award | 38,750 | $N/A | $0 | |
| Feb 5, 2026 | Bolno Paul | Executive | Award | 1,000,000 | $N/A | $0 | |
| Feb 5, 2026 | Bolno Paul | Executive | Award | 165,000 | $N/A | $0 | |
| Feb 5, 2026 | Moran Kyle | Chief Financial Officer | Award | 273,750 | $N/A | $0 | C-Suite |
| Feb 5, 2026 | Moran Kyle | Chief Financial Officer | Award | 45,625 | $N/A | $0 | C-Suite |
| Dec 11, 2025 | Gsk Plc | Executive | Purchase | 1,470,000 | $19.00 | $27.9M | Large |
| Dec 9, 2025 | Moran Kyle | Executive | Option Exercise | 36,000 | $8.17 | $294.1K | |
| Dec 9, 2025 | Moran Kyle | Executive | Sale | 36 | $20.25 | $729 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 12 | $127.9M | 66.7% |
Sale(S) | 126 | $50.7M | 26.4% |
Exercise(M) | 54 | $7.6M | 4.0% |
Other(J) | 2 | $5.4M | 2.8% |
Award(A) | 52 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Conversion(C) | 3 | $0 | 0.0% |
Insiders at Wave Life Sciences Ltd. are accumulating shares at an accelerated pace. With 23 insiders making 250 transactions totaling $127.9M in purchases versus $50.7M in sales, the net buying activity of $77.2M signals strong executive confidence. Plc Gsk (Executive) leads the buying activity with $44.4M in transactions across all time.